Hughes Financial Services’s KalVista Pharmaceuticals KALV Stock Holding History

Hughes Financial Services’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4	Closed	-$81	–	1895
2026 Q1	$81	Buy	4 +3	+300%	+$48	﹤0.01%	1343
2025 Q4	$16	Buy	+1	New	+$13	﹤0.01%	1243

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Hughes Financial Services's KALV Position: Q2 2026 in Review

Hughes Financial Services sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 4 shares — an estimated $81 sold.

Hughes Financial Services first reported a position in KALV in Q4 2025 and held it in 2 quarters. The position peaked at $81 in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Hughes Financial Services reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Hughes Financial Services sold 4 KalVista Pharmaceuticals shares in Q2 2026, an estimated $81.
Hughes Financial Services first reported a position in KalVista Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Hughes Financial Services's KalVista Pharmaceuticals position peaked at $81 in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.